What is Phlow?
Phlow operates as a modern contract development and manufacturing organization (CDMO), focused on bringing innovative medicines to life through advanced development and manufacturing capabilities within the United States. The company leverages scientific expertise, world-class manufacturing facilities, and tech-enabled processes to establish new industry standards. Phlow's mission is to increase speed to market for new therapies, reduce manufacturing waste, and promote environmentally conscious production methods, ultimately contributing to healthier and more resilient communities. Its operations are geared towards supporting both government and private industry clients in their drug development endeavors.
How much funding has Phlow raised?
Phlow has raised a total of $107M across 4 funding rounds:
Unspecified
$15M
Series A
$20M
Series B
$35M
Series C
$37M
Unspecified (2020): $15M, investors not publicly disclosed
Series A (2021): $20M, investors not publicly disclosed
Series B (2023): $35M, investors not publicly disclosed
Series C (2025): $37M featuring Align Private Capital
Key Investors in Phlow
Align Private Capital
Align Private Capital is a women-owned, SEC registered investment advisor that specializes in alternative investing for Single Family Offices (SFOs). Founded in 2014, the firm utilizes a proprietary network of over 100 SFOs and sector experts to source direct investment opportunities across various asset classes and geographies.
What's next for Phlow?
With the recent infusion of capital and a strategic investment, Phlow is poised to further enhance its advanced development and manufacturing capabilities. This enterprise-level funding is expected to fuel expansion initiatives, potentially including the scaling of production capacity, investment in cutting-edge technologies, and the broadening of its service offerings to a wider client base. The company's focus on domestic pharmaceutical manufacturing and its commitment to sustainable practices position it favorably to capitalize on growing demand for resilient and efficient drug supply chains. Phlow's strategic direction likely involves solidifying its role as a leader in innovative pharmaceutical manufacturing solutions.
See full Phlow company page
